High-Grade Progression Confers Poor Survival in Pancreatic Neuroendocrine TumorsJohan Botling, Joakim Crona, Ángela Lamarca et al.|Neuroendocrinology|2019Cited by 62
International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine TumorsCharlotte M. Heidsma, E.J.M. Nieveen van Dijkum, Josefine Kjaer et al.|Neuroendocrinology|2021Cited by 13
Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine TumorsJosefine Kjaer, Peter Stålberg, Thomas E. Clancy et al.|Annals of Surgery Open|2022Cited by 10
Overall Survival in Patients with Stage IV Pan‐NET Eligible for Liver TransplantationJosefine Kjaer, Olov Norlén, Sara Smith et al.|World Journal of Surgery|2022Cited by 9
Long-term outcome after resection and thermal hepatic ablation of pancreatic neuroendocrine tumour liver metastasesJosefine Kjaer, Olov Norlén, Peter Stålberg et al.|BJS Open|2021Cited by 9